Q03164 (KMT2A_HUMAN) Homo sapiens (Human)

Histone-lysine N-methyltransferase 2A UniProtKBInterProSTRINGInteractive Modelling

3969 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; )

Molecule Processing
MLL cleavage product N320
MLL cleavage product C180

Sequence Features

Add
 1155Zinc
 1158Zinc
 1161Zinc
 1167Zinc
 1170Zinc
 1173Zinc
 1189Zinc
 1194Zinc
 3909Zinc
 3957Zinc
 3959Zinc
 3964Zinc
 1362Breakpoint for translocation to form KMT2A-FRYL fusion protein
 3765Important for WDR5-recognition and binding
 30A -> G (in dbSNP:rs9332745) VAR_021317 dbSNP
 53A -> V (in dbSNP:rs9332747) VAR_021318 dbSNP
 502E -> K (in dbSNP:rs9332772) VAR_021319 dbSNP
 1975Q -> P (in dbSNP:rs693598) VAR_052652 dbSNP
 2319S -> T (in dbSNP:rs9332837) VAR_021320 dbSNP
 2354P -> R (in dbSNP:rs9332838) VAR_021321 dbSNP
 2387Q -> R (in dbSNP:rs9332839) VAR_021322 dbSNP
 3714V -> I (in dbSNP:rs9332859) VAR_021323 dbSNP
 3773S -> A (in dbSNP:rs9332861) VAR_021324 dbSNP
 169-180A.T hook 1
 217-227A.T hook 2
 301-309A.T hook 3
 1147-1195CXXC-type
 1431-1482PHD-type 1
 1479-1533PHD-type 2
 1566-1627PHD-type 3
 1870-1910C2HC pre-PHD-type
 1931-1978PHD-type 4
 1334-1335Breakpoint for translocation to form KMT2A-ZFYVE19 oncogene
 1362-1363Breakpoint for translocation to form KMT2A-AF3P21 and KMT2A-KNL1 oncogenes
 1362-1363Breakpoint for translocation to form KMT2A-CENPK oncogene
 1406-1407Breakpoint for translocation to form KMT2A-AFF4 fusion protein
 1444-1445Breakpoint for translocation to form KMT2A-GAS7 oncogene
 1444-1445Breakpoint for translocation to form KMT2A-LPP
 2666-2667Cleavage; by TASP1, site 1
 2718-2719Cleavage; by TASP1, site 2
 1148-1194Zinc finger, CXXC-type
IPR002857PF02008
 1481-1532Zinc finger, PHD-finger
IPR019787PF00628
 1569-1626Zinc finger, PHD-finger
IPR019787PF00628
 2024-2071FY-rich, N-terminal
IPR003888PF05964
 3669-3748FY-rich, C-terminal
IPR003889PF05965
 3840-3944SET domain
IPR001214PF00856

Sequence Alignments

MLL cleavage product N320 1-2718; PRO_0000390949

DescriptionOligo-stateLigandsStructureRange
Crystal structure of MLL1 PHD3-Bromo complexed with H3(1-9)K4me3 peptide Heteromer
P68431;
ZN;3lqj 1566-1779
Assess
Crystal structure of MLL1 PHD3-Bromo complexed with H3(1-9)K4me2 peptide Heteromer
P68431;
ZN;3lqi 1566-1778
Assess
Crystal structure of human menin in complex with MLL1 and LEDGF Heteromer
O00255; O75475;
CHD;GGB;0BR;GLV;SO4;3u88 103-135
Assess
Solution structure of LEDGF/p75 IBD in complex with MLL1 peptide (140-160) Heteromer
O75475;
2msr 140-160
Assess
Human menin in complex with MLL peptide Heteromer
O00255;
SO4;1PE;4gq6 6-15
Assess
Crystal structure of human menin in complex with MLL1 Heteromer
O00255;
3u85 6-13
Assess
Crystal structure of MLL1 PHD3-Bromo in the free formmonomer ZN;3lqh 1566-1778
Assess
Solution structure of the nonmethyl-CpG-binding CXXC domain of the leukaemia-associated MLL histone…monomer ZN;2j2s 1143-1214
Assess
The solution structure of the PHD3 finger of MLLmonomer ZN;2kyu 1564-1628
Assess
Solution structure of MLL CXXC domainmonomer ZN;2jyi 1147-1203
Assess
Solution structure of MLL CXXC domain in complex with palindromic CPG DNAmonomer ZN;2kkf 1147-1203
Assess
Crystal structure of MLL CXXC domain in complex with a CpG DNAmonomer ZN;4nw3 1150-1200
Assess
Solution structure of the LEDGF/p75 IBD - MLL1 (aa 111-160) complexmonomer 6emq 111-160
Assess
Solution structure of MLL1 PHD3-Cyp33 RRM chimeric proteinmonomer 2ku7 1585-1628
Assess
Solution structure of MLL-IBD complexmonomer 2mtn 122-160
Assess
Oligo-stateLigandsQMEANTemplateRangeSeq id (%)
monomer ALA;ZN;-1.243lqj.2.A1566-1778
100.00
Assess
monomer ZN;-4.076aze.1.A1566-1765
21.34
Assess

MLL cleavage product C180 2719-3969; PRO_0000390950

DescriptionOligo-stateLigandsStructureRange
Cryo-EM structure of human MLL1-NCP complex, binding mode1 Heteromer
P02281; P06897; P61964; P62799; P84233; Q15291; Q9UBL3;
SAH;ZN;LYS;GLN;6kix 3764-3969
Assess
Cryo-EM structure of human MLL1-NCP complex, binding mode2 Heteromer
P02281; P06897; P61964; P62799; P84233; Q15291; Q9UBL3;
SAH;ZN;6kiz 3764-3969
Assess
Cryo-EM structure of human MLL1-ubNCP complex (3.2 angstrom) Heteromer
P02281; P06897; P61964; P62799; P62979; P84233; Q15291; Q9UBL3;
SAH;ZN;LYS;GLN;6kiu 3764-3969
Assess
Cryo-EM structure of human MLL1-ubNCP complex (4.0 angstrom) Heteromer
P02281; P06897; P61964; P62799; P62979; P84233; Q15291; Q9UBL3;
SAH;ZN;6kiv 3764-3969
Assess
Ternary Complex of the Mixed Lineage Leukaemia (MLL1) SET Domain with the cofactor product S-Adenos… Heteromer
P68433;
ZN;SAH;GOL;2w5z 3790-3969
Assess
The crystal structure of MLL1 (N3861I/Q3867L) in complex with RbBP5 and Ash2L Heteromer
Q15291; Q9UBL3;
SAH;ZN;5f6l 3814-3969
Assess
Cryo-EM structure of MLL1 core complex bound to the nucleosome Heteromer
P02281; P06897; P61964; P62799; P84233; Q15291; Q9C005; Q9UBL3;
SAH;ZN;6pwv 3814-3969
Assess
Cryo-EM structure of MLL1 in complex with RbBP5 and WDR5 bound to the nucleosome Heteromer
P02281; P06897; P61964; P62799; P84233; Q15291;
SAH;ZN;6pww 3814-3969
Assess
Structural basis for cooperative transcription factor binding to the CBP coactivator Heteromer
P06876; P45481;
2agh 2839-2869
Assess
Crystal structure of the KIX domain of CBP in complex with a MLL/c-Myb chimera Heteromer
P01103; Q92793;
12×GOL; 42×CL;5svh 2843-2869
Assess
Allosteric communication in the KIX domain proceeds through dynamic re-packing of the hydrophobic c… Heteromer
Q92793;
2lxs 2840-2858
Assess
Allosteric communication in the KIX domain proceeds through dynamic re-packing of the hydrophobic c… Heteromer
P16220; Q92793;
2lxt 2840-2858
Assess
X-ray structure of WDR5-MLL1 Win motif peptide binary complex Heteromer
P61964;
4esg 3755-3770
Assess
Structure of WDR5 bound to MLL1 peptide Heteromer
P61964;
SO4;3eg6 3762-3770
Assess
Structural and biochemical insights into MLL1 core complex assembly and regulation. Heteromer
P61964; Q15291;
3p4f 3762-3770
Assess
Structural basis of WDR5-MLL interaction Heteromer
P61964;
SO4;3emh 3764-3769
Assess
Binary Complex of the Mixed Lineage Leukaemia (MLL1) SET Domain with the cofactor product S-Adenosy…monomer ZN;SAH;2w5y 3793-3969
Assess
The Crystal Structure of MLL1 SET domain with N3816I/Q3867L mutationmonomer ZN;SAH;5f5e 3814-3969
Assess
MLL1 SET N3861I/Q3867L bound to inhibitor 18 (TC-5153)monomer ZN;Q2V;6u9k 3813-3968
Assess
MLL1 SET N3861I/Q3867L bound to inhibitor 12 (TC-5140)monomer ZN;Q2P;6u9r 3813-3968
Assess
MLL1 SET N3861I/Q3867L bound to inhibitor 14 (TC-5139)monomer Q34;ZN;6u9n 3814-3968
Assess
MLL1 SET N3861I/Q3867L bound to inhibitor 16 (TC-5109)monomer ZN;Q2M;6u9m 3814-3968
Assess

Homology models built on isoform sequence

IsoformOligo-stateLigandsQMEANTemplateRangeSeq id (%)
Isoform 2monomerALA;ZN;-1.223lqj.2.A1528-1740
100.00
Assess
Isoform 2monomer-2.146boz.1.B3781-3908
30.71
Assess
Isoform 2monomerZN;-4.016kiv.1.K3726-3931
100.00
Assess
Isoform 2monomerZN;-4.462ri7.1.A1528-1728
20.61
Assess
Isoform 3monomerALA;ZN;-1.533lqj.2.A1566-1781
100.00
Assess
Isoform 3monomerZN;-1.635lsy.1.A3820-3972
32.24
Assess
Isoform 3monomerZN;-3.806kiz.1.L3767-3972
100.00
Assess
Isoform 3monomerZN;-4.312f6j.1.B1566-1768
21.34
Assess